4-APB

4-(2-Aminopropyl)benzofuran (4-APB) is a monoamine releasing agent and novel designer drug of the benzofuran family. It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA). The drug was first detected, in Europe, by 2011.
Wikipedia contributors, "4-APB", Wikipedia, revision 1347373941, retrieved 20 November 2026, source, CC BY-SA 4.0.